Hims & Hers Health, Inc.·4

Mar 17, 4:28 PM ET

Dudum Andrew 4

Research Summary

AI-generated summary

Updated

Hims & Hers (HIMS) CEO Andrew Dudum Receives RSU Settlement; Shares Withheld

What Happened
Andrew Dudum, CEO of Hims & Hers (HIMS), reported the settlement of performance and service-based restricted stock units (RSUs) that vested. The filing shows 164,369 shares were acquired on conversion/exercise of derivatives (RSU settlement). At the same time, the issuer withheld a total of 526,486 shares to satisfy tax withholding obligations, valued at $24.77 per share for a total withholding value of $13,041,058.

Key Details

  • Transaction date: March 13, 2026; Form 4 filed March 17, 2026.
  • Acquired: 164,369 shares from RSU conversion (transaction code M).
  • Withheld/disposed for tax withholding: 436,190 shares ($10,804,426) and 90,296 shares ($2,236,632) at $24.77 per share (transaction code F); combined value $13,041,058.
  • Several zero-dollar derivative disposal lines (35,242; 35,447; 74,530; 19,150) correspond to portions of the 164,369-share RSU settlement.
  • Footnotes indicate these were RSU vesting and net/share-withholding actions (not open-market sales).
  • Shares owned after the transaction: not specified in the excerpt provided.
  • Filing timeliness: No late filing flag indicated.

Context

  • This was an RSU vesting/settlement event, not an open-market sale or new purchase. The withheld shares represent tax withholding (a common, administrative step) rather than discretionary selling by the insider.
  • Transaction codes: M = exercise/conversion of derivative (RSU settlement); F = payment of tax liability via share withholding.
  • For retail investors, withholding upon vesting is routine and does not necessarily signal the insider’s view of the company’s prospects.